Clinical Trial Update: Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) After Axillary Dissection for Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Mediclore, a mixed solid of poloxamer, gelatin and chitosan, for anti-adhesive effects and safety after axillary dissection in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Mediclorе

Snippet

Sponsor: Samsung Medical Center | Conditions: Breastcancer, Surgery: Axillary Dissection | Phase 3 | Status: UNKNOWN